Kiora Pharmaceuticals Competitors and Similar CompaniesClear all

Kiora Pharmaceuticals's competitors and similar companies include Heron Therapeutics, Camurus and Sosei Heptares.

	Kiora Pharmaceuticals Kiora Pharmaceuticals (formerly known as Panoptes Pharma) is a clinical-stage biotech company focused on developing small molecule-based therapies for the treatment of severe eye diseases.	Heron Therapeutics Heron Therapeutics (formerly A.P. Pharma) is a biotechnology company engaged in drug discovery and development.	Camurus Camurus is a research-based pharmaceutical company that develops medicines for severe and chronic conditions.	Sosei Heptares Sosei Heptares is a biopharmaceutical company that specializes in drug development.
Founding Date	Founding Date 2013	Founding Date 1983	Founding Date 1991	Founding Date 1990
Type	Type Subsidiary	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development pharma therapy	Tags Healthcare biotech drug development pharma therapy	Tags Healthcare biotech drug development pharma therapy	Tags Healthcare biotech drug development pharma therapy
Locations	Locations Wien, AT HQ	Locations San Diego, US HQ	Locations Lund, SE HQ Sydney, AU Mannheim, DE Duxford, GB	Locations Tokyo, JP HQ Dublin, IE Cambridge, GB London, GB
Employees	Employees 1025% increase	Employees 20333% decrease	Employees 265	Employees 387
Valuation ($)	Valuation ($) N/A	Valuation ($) 268.5 m	Valuation ($) 3.4 b	Valuation ($) 697 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $154.9m (FY, 2025)	Revenue (est.) kr2.3b (FY, 2025)	Revenue (est.) ¥29.6b (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods $41.3m (FY, 2025)	Cost of goods kr138.7m (FY, 2025)	Cost of goods ¥7.3b (FY, 2025)
Gross profit	Gross profit N/A	Gross profit $113.6m (FY, 2025)	Gross profit kr2.1b (FY, 2025)	Gross profit ¥24b (FY, 2025)
Net income	Net income N/A	Net income ($20.2m) (FY, 2025)	Net income kr735.6m (FY, 2025)	Net income (¥12.5b) (FY, 2025)